898482-73-0Relevant academic research and scientific papers
QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE
-
Paragraph 0682, (2019/06/07)
Provided herein are quinolines, e.g., a compound of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes. Also provided herein are methods of their use for modulating the activity of a sarcoplasmic/endoplasmic reticulum C2+ ATPase.
QUINOLINES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-CAUSED DISEASES
-
Page/Page column 201, (2016/03/22)
Provided herein are quinolines, e.g., a compound of Formula (I) or (IB), pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of an endoplasmic reticulum stress-caused disease. Also provided herein are methods of their use for reducing endoplasmic reticulum stress and modulating the activity of a sarcoplasmic/endoplasmic reticulum Ca2+ ATPase.
Pigment dispersing agent, pigment composition and pigment dispersion
-
Page/Page column 23, (2008/06/13)
A pigment dispersing agent wherein a quinophthalone structure is bonded to a triazine structure through an arylene group or a heteroaromatic ring and a basic functional group is bonded to triazine ring through a connecting group which pigment dispersing a
